Claritev Corporation (CTEV)

Market Cap	280.07M -20.5%
Revenue (ttm)	965.41M +3.7%
Net Income	-284.28M
EPS	-17.30
Shares Out	16.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111,132
Open	16.99
Previous Close	17.06
Day's Range	16.56 - 17.81
52-Week Range	12.04 - 74.07
Beta	0.54
Analysts	Strong Buy
Price Target	41.75 (+146.75%)
Earnings Date	May 7, 2026

About CTEV

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical neg...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1980
• Employees: 3,000
• Stock Exchange: NYSE
• Ticker Symbol: CTEV
• Website: https://www.claritev.com

Financial Performance

In 2025, Claritev's revenue was $965.41 million, an increase of 3.74% compared to the previous year's $930.62 million. Losses were -$284.28 million, -82.73% less than in 2024.

Analyst Summary

According to 4 analysts, the average rating for CTEV stock is "Strong Buy." The 12-month stock price target is $41.75, which is an increase of 146.75% from the latest price.

Price Target

$41.75

(146.75% upside)

Analyst Consensus: Strong Buy